Uniphar PLC has entered a new banking syndicate with a total capacity of US$601 million
Irish-listed healthcare group Uniphar PLC has expanded its banking facilities to support its international growth plans. The total committed facilities came to US$440 million, with an additional accordion to increase capacity by a further US$160 million. The transaction involved Uniphar returning to its existing banking syndicate of Bank of Ireland, AIB, HSBC and RBC, while adding three new international banks—Barclays, ING and Citizens—to complete a full refinancing of the company’s facilities.
Uniphar is a global partner to pharmaceutical and medtech manufacturers working to improve patient access to medicines in Europe and around the world. It provides outsourced and specialized services to its clients and leverages strong relationships with over 200 of the world’s best-known pharmaco-medical manufacturers in multiple geographies. Uniphar operates across three core divisions: pharmaceuticals—a global business providing on-demand and medicine-sourcing solutions along with outsourced specialist services to pharmaceutical manufacturers; medtech—a leading European medical device distributor with a presence in 21 markets; and supply chain and retail—a market leader in Ireland with around 50% of the wholesale market and four nationwide pharmacy symbol groups. Uniphar is listed on the LSE and Euronext Dublin.
Oaklins’ team in Ireland acted as the exclusive debt advisor to Uniphar in this transaction, assisting in all aspects, from initiating the refinancing and leading interactions with multiple domestic and international banks, to structuring and negotiating premium terms. This deal complements a long list of advisory services the team has provided to Uniphar.
Talk to the deal team
Related deals
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn moreAgrova International has acquired Sunrise Eggs
Agrova International, led by its founder Jurijs Adamovičs, has acquired 100 percent of the shares in Sunrise Eggs, a UK-based egg production and distribution company. This acquisition significantly expands Agrova’s operational footprint and strengthens its position as a pan-European player in the egg and egg protein industry. The transaction was supported with funding from Accession Capital Partners (ACP), a growth capital provider with experience in the agriculture sector.
Learn moreSmile Invest has secured debt financing for the acquisition of RB+ Groep
Smile Invest has successfully acquired a majority stake in RB+ Groep, a specialist in comprehensive fire prevention solutions operating under the brands Van der Aa, Firejob and Preficon Europe, with a strong focus on constructional fire prevention. This transaction supports RB+’s growth ambitions and enables the company to expand into adjacent and international markets.
Learn more